|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Lucira Health, Inc. (LHDX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
38,310,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lucira Health is a medical technology company focused on the development and commercialization of infectious disease test kits. Co. has developed a testing platform that produces molecular testing in a single-use test kit that is powered by two AA batteries and fits in the palm of a hand. Co.'s primary commercially available polymerase chain reaction-quality diagnostic test is the LUCIRA COVID-19 All-In-One Test Kit.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
30,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$51,300 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
974,177 |
| Total Sell Value |
$0 |
$0 |
$0 |
$985,816 |
| Total People Sold |
0 |
0 |
0 |
8 |
| Total Sell Transactions |
0 |
0 |
0 |
27 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Narido Richard Clavano |
Chief Financial Officer |
• – – |
2023-03-07 |
4 |
S |
$0.45 |
$1,072 |
D/D |
(2,382) |
77,910 |
|
- |
|
| Collins Kevin Walter |
Chief Revenue Officer |
• – – |
2023-03-07 |
4 |
S |
$0.48 |
$39,224 |
D/D |
(81,717) |
234,903 |
|
- |
|
| Narido Richard Clavano |
Chief Financial Officer |
• – – |
2023-03-06 |
4 |
S |
$0.57 |
$1,089 |
D/D |
(1,910) |
80,292 |
|
- |
|
| Narido Richard Clavano |
Chief Financial Officer |
• – – |
2023-03-03 |
4 |
S |
$1.00 |
$27,263 |
D/D |
(25,091) |
82,202 |
|
- |
|
| Engelson Erik T. |
President and Chief Executive |
• • – |
2023-03-03 |
4 |
S |
$1.03 |
$657,306 |
D/D |
(634,666) |
23,282 |
|
- |
|
| Engelson Erik T. |
President and Chief Executive |
• • – |
2023-03-03 |
4 |
OE |
$0.82 |
$471,226 |
D/D |
574,666 |
657,948 |
|
- |
|
| Allen Anthony Joseph |
Chief Operations Officer |
• – – |
2023-03-03 |
4 |
S |
$1.00 |
$8,405 |
D/D |
(8,405) |
136,520 |
|
- |
|
| Collins Kevin Walter |
Chief Revenue Officer |
• – – |
2023-03-03 |
4 |
S |
$1.15 |
$34,617 |
D/D |
(30,102) |
316,620 |
|
- |
|
| Kashmolah Ghazi |
Ex VP & Chief Quality Officer |
• – – |
2023-02-16 |
4 |
S |
$0.27 |
$1,358 |
D/D |
(5,028) |
134,075 |
|
- |
|
| Allen Anthony Joseph |
Chief Operations Officer |
• – – |
2022-12-20 |
4 |
S |
$0.16 |
$682 |
D/D |
(4,263) |
144,925 |
|
- |
|
| Boeding Chad |
CEO of 10% owner |
– – – |
2022-12-14 |
4 |
A |
$0.00 |
$0 |
I/I |
982,417 |
1,014,593 |
|
- |
|
| Boeding Chad |
CEO of 10% owner |
– – – |
2022-12-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,124,349) |
32,176 |
|
- |
|
| Narido Richard Clavano |
Interim CFO |
• – – |
2022-12-01 |
4 |
S |
$0.36 |
$570 |
D/D |
(1,583) |
107,293 |
|
- |
|
| Kashmolah Ghazi |
Ex VP & Chief Quality Officer |
• – – |
2022-11-28 |
4 |
S |
$0.42 |
$3,166 |
D/D |
(7,537) |
139,103 |
|
- |
|
| Collins Kevin Walter |
Chief Revenue Officer |
• – – |
2022-11-27 |
4 |
S |
$0.42 |
$4,060 |
D/D |
(9,666) |
346,722 |
|
- |
|
| Allen Anthony Joseph |
Chief Operations Officer |
• – – |
2022-11-21 |
4 |
S |
$0.33 |
$11,362 |
D/D |
(34,429) |
149,188 |
|
- |
|
| Kashmolah Ghazi |
Ex VP & Chief Quality Officer |
• – – |
2022-11-17 |
4 |
S |
$0.37 |
$12,382 |
D/D |
(33,247) |
146,640 |
|
- |
|
| Kashmolah Ghazi |
Ex VP & Chief Quality Officer |
• – – |
2022-11-16 |
4 |
S |
$0.35 |
$1,677 |
D/D |
(4,790) |
179,887 |
|
- |
|
| Allen Anthony Joseph |
Chief Operations Officer |
• – – |
2022-09-20 |
4 |
S |
$1.39 |
$23,702 |
D/D |
(17,052) |
183,617 |
|
- |
|
| George Dan |
CFO and Treasurer |
• – – |
2022-09-18 |
4 |
S |
$1.38 |
$473 |
D/D |
(343) |
46,011 |
|
- |
|
| Engelson Erik T. |
President and Chief Executive |
• • – |
2022-09-15 |
4 |
B |
$1.82 |
$36,400 |
D/D |
20,000 |
83,282 |
2.81 |
- |
|
| Mitra Debkishore |
Chief Technology Officer |
• • – |
2022-09-01 |
4 |
S |
$1.69 |
$324 |
D/D |
(191) |
382,208 |
|
- |
|
| Collins Kevin Walter |
Chief Revenue Officer |
• – – |
2022-08-27 |
4 |
S |
$1.72 |
$14,758 |
D/D |
(8,580) |
356,388 |
|
- |
|
| Kashmolah Ghazi |
Ex VP & Chief Quality Officer |
• – – |
2022-08-25 |
4 |
S |
$1.93 |
$2,895 |
D/D |
(1,500) |
184,677 |
|
- |
|
| Kashmolah Ghazi |
Ex VP & Chief Quality Officer |
• – – |
2022-08-18 |
4 |
S |
$2.25 |
$7,875 |
D/D |
(3,500) |
177,257 |
|
- |
|
58 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
